These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 2518666

  • 1. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D, Serafińska D, Rudowski W, Hoffman S, Olański W, Gardzińska E, Popiel D, Jedrzejczak G, Czarnecka I.
    Pol Tyg Lek; ; 44(43-45):924-7. PubMed ID: 2518666
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W, Zietkiewicz W, Brudzyńska-Charewicz S, Bukowska D, Serafińska D, Rudowski W.
    Pol Tyg Lek; 1981 Aug 10; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract] [Full Text] [Related]

  • 4. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
    Grochowski J, Bilinska M, Stankiewicz D, Arkusiewicz E.
    Pol Przegl Chir; 1979 Jun 10; 51(6):623-7. PubMed ID: 116210
    [No Abstract] [Full Text] [Related]

  • 5. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W, Zietkiewicz W, Brudzyńska-Charewicz S, Bukowska D, Serafińska D, Rudowski W.
    Pol Tyg Lek; 1984 Apr 23; 39(17):557-61. PubMed ID: 6435103
    [No Abstract] [Full Text] [Related]

  • 6. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR, Zwissler O, Metzger E.
    Chirurg; 1975 Oct 23; 46(10):462-66. PubMed ID: 815075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
    Gerasimova LI, Moroz AF, Radkevich SA, Sveshnikov AI, Mizikin EV.
    Khirurgiia (Mosk); 1980 Nov 23; (11):36-41. PubMed ID: 6777578
    [No Abstract] [Full Text] [Related]

  • 10. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA, Jones RJ.
    Burns Incl Therm Inj; 1983 Jul 23; 9(6):433-9. PubMed ID: 6412970
    [Abstract] [Full Text] [Related]

  • 11. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E, Sima F, Savulian C, Petrovici M, Chersulick E, Costache G.
    Arch Roum Pathol Exp Microbiol; 1989 Jul 23; 48(3):237-51. PubMed ID: 2519634
    [Abstract] [Full Text] [Related]

  • 12. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C.
    Arch Roum Pathol Exp Microbiol; 1979 Jul 23; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract] [Full Text] [Related]

  • 13. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D, Bukowska D, Sokołowska K, Nasiłowski W.
    Pol Tyg Lek; 1980 Jul 07; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U, Mansouri E, von Specht BU.
    Vaccine; 2004 Feb 17; 22(7):840-7. PubMed ID: 15040936
    [Abstract] [Full Text] [Related]

  • 15. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF, Kharitonova AM, Chanturiia TsK.
    Antibiotiki; 1983 May 17; 28(5):341-5. PubMed ID: 6410985
    [Abstract] [Full Text] [Related]

  • 16. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ, Lowbury EJ.
    Br J Exp Pathol; 1972 Dec 17; 53(6):659-64. PubMed ID: 4630411
    [Abstract] [Full Text] [Related]

  • 17. [Use of human anti-Pseudomonas immunoglobulins in treatment of children with burns].
    Bukowska D, Wegrzynowicz Z, Rudowski W, Kraj M, Rosiek A, Gardzińska E, Popiel D.
    Pol Tyg Lek; 1996 Jun 17; 51(23-26):331-3. PubMed ID: 9273523
    [Abstract] [Full Text] [Related]

  • 18. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
    Kawaharajo K, Homma JY.
    Jpn J Exp Med; 1977 Dec 17; 47(6):495-500. PubMed ID: 416253
    [Abstract] [Full Text] [Related]

  • 19. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Moroz AF, Antsiferova NG, Radkevich SA, Mishina VS.
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct 17; (10):74-80. PubMed ID: 6800165
    [Abstract] [Full Text] [Related]

  • 20. Treatment of experimental burn wound sepsis by postburn immunization with polyvalent Pseudomonas antigen.
    Nance FC, Hines JL, Fulton RE, Bornside GH.
    Surgery; 1970 Jul 17; 68(1):248-53. PubMed ID: 10483476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.